QA: Viracta Therapeutics Inc in us_pharma/2015

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001061027_2016_Viracta_Therapeutics_Inc.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001061027, Viracta Therapeutics Inc

  xvar xval
0 AssetsCurrent 46,988,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 14,000
3 remainder_Assets 0
4 LiabilitiesCurrent 18,999,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 19,118,694
9 ResearchAndDevelopmentExpense 22,197,175
10 remainder_Expenses 648,232
11 remainder_Revenues 3,683,237
12 remainder_NetIncome 3,635,876
13 remainder_ComprehensiveNetIncome -4,000
  yvar yval
0 Assets 47,002,000
1 Liabilities 18,999,000
2 Expenses 41,964,101
3 Revenues 3,683,237
4 StockholdersEquity 28,003,000
5 NetIncome -34,644,988
6 ComprehensiveNetIncome -34,646,988
7 BaseVar 57,644,107
8 EconomicCapitalRatiobeforeLimitedLiability 0.800
9 EconomicCapitalRatio 2.14

Edgar->Model Mapping

Feature Distribution

Change over Time